Hong Kong pharmaceutical stocks are going strong against the trend, with Healthcare Biotech rising more than 6%.

As of the deadline for submission, Canoya-B increased by 6.05%, Taige Pharmaceuticals rose by 4.87%, and Kingsley Biotechnology increased by 3.74%.